Barclays’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Barclays’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-231	Closed	-$60	–	5652
2025 Q1	$60	Buy	+231	New	+$97	﹤0.01%	5142

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Barclays's SYRA Position: Q2 2025 in Review

Barclays sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 231 shares — an estimated $60 sold.

Barclays first reported a position in SYRA in Q1 2025 and held it in 1 quarter. The position peaked at $60 in Q1 2025. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

Barclays reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Barclays sold 231 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $60.
Barclays first reported a position in Syra Health Corp. Class A Common Stock in Q1 2025 and held it in 1 quarter.
Barclays's Syra Health Corp. Class A Common Stock position peaked at $60 in Q1 2025.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.